Literature DB >> 11071589

Cytokine-driven inflammatory response is associated with the hypermetabolism of AIDS patients with opportunistic infections.

P García-Lorda1, P Serrano, M J Jiménez-Expósito, J Fraile, M Bulló, C Alonso, A Bonada, P Viciana, P P Luna, J Salas-Salvadó.   

Abstract

BACKGROUND: To assess a possible role of systemic inflammation in the resting metabolic response in AIDS patients with active secondary infections.
METHODS: Fifty-two patients with AIDS-defined criteria and concomitant active infections and 19 healthy subjects were studied. Measurements were as follows: body composition assessed by bioelectrical impedance; resting energy expenditure (REE) by 30-minute indirect calorimetry; cytokine concentrations (IL-6, IFNalpha, TNFalpha, sTNF-R1) by ELISA; C-reactive protein (CRP), erythrocyte sedimentation rate, fibrinogen, and nutritional parameters by standard techniques.
RESULTS: REE adjusted for fat-free mass (REEFFM) was significantly increased in AIDS patients despite 39% of them not being hypermetabolic. The patients were undernourished and were found to have increased levels of acute-phase proteins and increased concentrations of IL-6 and sTNF-R1 relative to controls. REE parameters were positively related to CRP, ESR, ferritin, IL-6, and sTNF-R1 and negatively related to albumin, prealbumin, and transferrin. CRP was an independent predictor of REEFFM in AIDS patients and explained 25% of its variability. Patients with severe inflammation (CRP > or = 37 mg/dL) were significantly hypermetabolic with respect to patients without inflammation (CRP < 6 mg/dL) and had higher levels of IL-6 and sTNF-R1 and lower levels of albumin and prealbumin. Although no significant differences were observed with respect to the infection type, patients with tuberculosis and Pneumocystis carinii infections had higher resting metabolic and inflammatory responses, whereas patients with recurrent bacterial pneumonia were normometabolic and had lower levels of inflammatory markers.
CONCLUSIONS: Resting hypermetabolism observed in AIDS patients with concurrent active infections is related to the presence and severity of systemic cytokine-driven inflammatory response, which could reflect the type of secondary infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11071589     DOI: 10.1177/0148607100024006317

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  7 in total

1.  Proinflammatory cytokines and the hypermetabolism of children with sickle cell disease.

Authors:  Jacqueline M Hibbert; Lewis L Hsu; Sam J Bhathena; Ikovwa Irune; Bismark Sarfo; Melissa S Creary; Beatrice E Gee; Ali I Mohamed; Iris D Buchanan; Ahmad Al-Mahmoud; Jonathan K Stiles
Journal:  Exp Biol Med (Maywood)       Date:  2005-01

Review 2.  Energy metabolism in cachexia.

Authors:  Maria Rohm; Anja Zeigerer; Juliano Machado; Stephan Herzig
Journal:  EMBO Rep       Date:  2019-03-19       Impact factor: 8.807

3.  Increase in muscle mitochondrial biogenesis does not prevent muscle loss but increased tumor size in a mouse model of acute cancer-induced cachexia.

Authors:  Xiao Wang; Alicia M Pickrell; Teresa A Zimmers; Carlos T Moraes
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

4.  Using Routine Laboratory Markers and Immunological Indicators for Predicting Pneumocystis jiroveci Pneumonia in Immunocompromised Patients.

Authors:  Guoxing Tang; Shutao Tong; Xu Yuan; Qun Lin; Ying Luo; Huijuan Song; Wei Liu; Shiji Wu; Liyan Mao; Weiyong Liu; Yaowu Zhu; Ziyong Sun; Feng Wang
Journal:  Front Immunol       Date:  2021-04-12       Impact factor: 7.561

5.  Clinical Performance of BAL Metagenomic Next-Generation Sequence and Serum (1,3)-β-D-Glucan for Differential Diagnosis of Pneumocystis jirovecii Pneumonia and Pneumocystis jirovecii Colonisation.

Authors:  Li Liu; Mingjuan Yuan; Yi Shi; Xin Su
Journal:  Front Cell Infect Microbiol       Date:  2021-12-22       Impact factor: 5.293

6.  Nuclear magnetic resonance based profiling of biofluids reveals metabolic dysregulation in HIV-infected persons and those on anti-retroviral therapy.

Authors:  Saif Ullah Munshi; Bharat Bhushan Rewari; Neel Sarovar Bhavesh; Shahid Jameel
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

7.  Plasma Metabolomics Biosignature According to HIV Stage of Infection, Pace of Disease Progression, Viremia Level and Immunological Response to Treatment.

Authors:  Bruno Scarpellini; Michelle Zanoni; Maria Cecilia Araripe Sucupira; Hong-Ha M Truong; Luiz Mario Ramos Janini; Ismael Dale Cotrin Segurado; Ricardo Sobhie Diaz
Journal:  PLoS One       Date:  2016-12-12       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.